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ABSTRACT Aphthoviruses use a conserved Arg-Gly-Asp
triplet for attachment to host cells and this motif is believed
to be essential for virus viability. Here we report that this
triplet—which is also a widespread motif involved in cell-to-
cell adhesion—can become dispensable upon short-term evo-
lution of the virus harboring it. Foot-and-mouth disease virus
(FMDV), which was multiply passaged in cell culture, showed
an altered repertoire of antigenic variants resistant to a
neutralizing monoclonal antibody. The altered repertoire in-
cludes variants with substitutions at the Arg-Gly-Asp motif.
Mutants lacking this sequence replicated normally in cell
culture and were indistinguishable from the parental virus.
Studies with individual FMDV clones indicate that amino acid
replacements on the capsid surface located around the loop
harboring the Arg-Gly-Asp triplet may mediate in the dis-
pensability of this motif. The results show that FMDV qua-
sispecies evolving in a constant biological environment have
the capability of rendering totally dispensable a receptor
recognition motif previously invariant, and to ensure an
alternative pathway for normal viral replication. Thus, vari-
ability of highly conserved motifs, even those that viruses have
adapted from functional cellular motifs, can contribute to
phenotypic f lexibility of RNA viruses in nature.
Replication fidelity for RNA viruses is several-thousand-fold
lower than for DNA based organisms (1–3). This is the
consequence of a lack of proofreading activities associated
with RNA polymerases and retroviral transcriptases. The
outcome of the highly mutable viral genomes is that RNA viral
populations form complex distributions of mutant genomes
termed viral quasispecies (4–7). The evolutionary potential of
such systems is largely unexplored. It is often assumed that
nucleotide sequence conservation is linked to functionally
essential domains of proteins or of regulatory genomic regions.
This is often extended to RNA viruses, and statements cor-
relating sequence conservation with functional essentiality
abound in the literature of RNA viruses. But even this rule,
which is very rooted in DNA genetics, may fail for RNA
viruses, as documented in this report.
Work with the important animal pathogen foot-and-mouth
disease virus (FMDV) by several groups over the last decade
has permitted identification of a highly conserved, essential
Arg-Gly-Asp domain on capsid protein VP1, which is involved
in recognition of cellular receptors for this virus, including
avb3 (8–13¶). Structural and functional work with rhinovirus
and poliovirus indicated that the receptor recognition domain
of these viruses was located at a depression or canyon inside
the viral capsid (14, 15). This separated the receptor recog-
nition site, conveniently hidden from immune attack, from
variable surface residues corresponding to antigenic sites. The
need to conserve critical residues was again equated with
prohibition to change. It was work with FMDV that changed
this picture dramatically. First, the FMDV structures deter-
mined by Stuart and colleagues (16–19) revealed that, contrary
to other picornaviruses, no canyon or pit was present on the
smooth FMDV surface. Furthermore, the critical receptor
recognition Arg-Gly-Asp domain was located on a highly
mobile loop (the G–H loop of VP1), which was also a major
antigenic site for the virus (20–22). Additional structural work
by Fita and colleagues (23) further indicated that the Arg-
Gly-Asp motif is not only part of the receptor recognition site
but it also interacts directly with some anti-viral neutralizing
antibodies. Recent work with poliovirus and rhinovirus has
also suggested that, interestingly, there is significant overlap
between the subset of amino acid residues involved in receptor
recognition and those belonging to antigenic sites (24i). In
addition to implications for coevolution of antigenicity and cell
tropism, these observations emphasize one of the major evo-
lutionary mechanisms used by RNA viruses: extremely active
mutant production with continuous action of negative selec-
tion (3, 25). The Arg-Gly-Asp triplet is conserved not because
it is not subjected to antibody attack but because the viruses
that incorporate variations at this site cannot survive and, thus,
they cannot be isolated and analyzed.
Here we document that the evolutionary capability of
FMDV embraces the possibility that upon replication of the
virus in a constant cell culture environment, even the Arg-
Gly-Asp (RGD) motif may become dispensable.
MATERIALS AND METHODS
Virus and Monoclonal Antibody (mAb). FMDV C-S8c1 is a
plaque-purified derivative of the vaccine strain FMDV C-S8
(Santa Pau, Spain) (26). The passage history of FMDV C-S8c1
in cell culture involved three successive plaque isolations and
an amplification from about 105 to 108 plaque-forming units
(pfu) in BHK-21 cells. FMDV C-S8c1p100 is the C-S8c1 virus
propagated 100 times in cell culture. Serial passages of FMDV
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C-S8c1 were performed by infecting a monolayer of about 2 3
106 BHK-21 cells with 4 3 106 to 8 3 106 pfu (multiplicity of
infection 2–4 pfu per cell) (27). The progeny of each infection
was used to infect a fresh cell monolayer at the same multi-
plicity of infection. It must be emphasized that contrary to
persistent infections in which the BHK-21 cells coevolved with
FMDV (28), in the present experiments BHK-21 cells did not
evolve, since a fresh monolayer from the same clonal stock of
cells was used for each viral passage. mAb SD6 recognizes an
extensively characterized epitope within the G–H loop of VP1
(29).
Selection of FMDV Mutants Resistant to mAb SD6. Mutants
resistant to neutralization by mAb SD6 (MARM) were se-
lected either from FMDV C-S8c1 and FMDV C-S8c1p100 or
from plaque-purified viral clones derived from the same viral
populations. Selection of plaque-purified viruses ensured that
each MARM analyzed originated from an independent mu-
tational event. About 105-106 pfu of virus were incubated for
2 hr at 4°C with a 1:1 dilution of the mAb (supernatant of the
SD6 hybridoma culture), and plated with a 1:50 dilution of the
same mAb in the agar overlay, as previously described (29).
Virus from a single plaque (about 105 pfu) was isolated and its
resistance to the antibody (no detectable reduction in the
number of plaques) tested in the neutralization assay (29). The
virus was amplified to about 108 pfu for nucleotide sequencing.
To determine the MARM frequency, 105 to 106 viral pfu
were incubated either in the presence or the absence of
antibodies and adsorbed onto BHK-21 monolayers following
described procedures (27). A 1:1 dilution of the supernatant of
an SD6 hybridoma culture suppressed plaque formation of 100
pfu of FMDV C-S8c1 without any significant decrease of
plaque numbers of resistant mutants previously selected with
SD6 (29).
Virus Growth Curves. Confluent BHK-21 cell monolayers
(2 3 106 cells) were infected at a multiplicity of infection of 10
pfu per cell with either FMDV C-S8c1 or FMDV C-S8c1p100
or mutants resistant to mAb SD6. After a 1 hr absorption
period at 37°C, monolayers were washed, and infection allowed
to proceed at 37°C as described. Samples (20 ml) were taken
at different times after infection for titration of infectivity (26).
Nucleotide Sequencing. The viral RNA encoding the FMDV
capsid (P1) region was retrotranscribed into cDNA with
primer 1: 59-GAAGGGCCCAGGGTTGGACT-39 (comple-
mentary to the RNA region encoding the 2A–2B junction,
residues 3869–3888). The cDNA was PCR amplified with
primer 1 and primer 2: 59-GCTGTGGTAAACGCCATCA-39
[complementary to the RNA region encoding the L (leader)
protease, residues 1063–1081]. For sequencing the VP1-coding
region primer 1 and primer 3: 59-GCACGCTTCATGCG-
CAC-39 (complementary to residues 3727–3743) were used.
The complete capsid (P1) region was sequenced with primers
1, 3, and 4 (59-GACCTTCACAAACCGGTCA-39, residues
3315–3333), 5 (59-GTTTCAGCCTCGTGGGACGC-39, resi-
dues 3058–3077), 6 (59-GCCGGCCAAGTAGGTGTTTGA-
39, residues 2807–2828), 7 (59-GGTTGGGGCTATGTTGGC-
39, residues 2497–2514), 8 (59-CCAGCCATTGCGCATG-
TACG-39, residues 2192–2211), 9 (59-CTAGAGACGCG-
CGTTC-39, residues 2047–2062), 10 (59-ACTGATGGCGTT-
GTC-39, residues 1759–1773), and 11 (59-CACTGGCAG-
CATAATTAAC-39, residues 1692–1710). PCRs were se-
quenced using thermosequenase (United States Biochemical/
Amersham).
Molecular Modeling. Using the crystallographic coordinates
of FMDV C-S8c1 (17), the substitutions found in the capsid of
FMDV C-S8c1p100, mutant (Asp-143-Gly) (see Table 2), have
been modeled with the program TURBO (32) by placing the side
chain atoms of the substituted amino acids in their standard
conformations. The model was then optimized by energy
minimization using the program X-PLOR (33).
RESULTS
Overcoming Restrictions to Variation: A New Repertoire of
Amino Acid Substitutions Among Antibody-Resistant Mu-
tants of FMDV. mAb SD6, which recognizes a continuous
epitope located within amino acids 136–147 of VP1 of FMDV
C-S8c1 (23, 29, 32, 33), was used to isolate resistant mutants.
Viruses C-S8c1 and its derivative C-S8c1p100, obtained by
propagating C-S8c1 in cell culture (see Materials and Methods)
were incubated with mAb SD6 and resistant mutants were
selected. To identify the mutations responsible for the resis-
tance phenotype, the sequence of the VP1-coding region was
determined. Sequences of 26 mutants isolated from FMDV
C-S8c1 and 31 mutants isolated from FMDV C-S8c1p100 were
compared with 56 additional mutants previously isolated from
FMDV C-S8c1 (29, 34) (Table 1). The amino acid substitutions
found in mutants derived from FMDV C-S8c1 affected only
VP1 residues Ala-138, Ser-139, and His-146 (Table 1 and Fig.
1). Both immunochemical (refs. 29 and 35, M.G.M. and E.D.,
unpublished work) and structural (23) results have shown that,
in addition to residues 138, 139, and 146, the highly conserved
VP1 amino acids 141–145 and 147 were critically involved in
recognition by mAb SD6 (Fig. 1). The finding of 86 antigenic
variants substituted only in 3 different residues out of the 10
that interact with the antibody paratope clearly demonstrates
the restrictions to variation that must be operating to keep
residues 141–145 of FMDV C-S8c1, which include the Arg-
Gly-Asp triplet, invariant (24, 35). In contrast, the sequences
of 31 SD6-resistant mutants isolated from FMDV C-S8c1p100
revealed a completely different, expanded repertoire of anti-
genic variants (Table 1), with most substitutions affecting the
highly conserved residues 142–145 (Fig. 1). Thus, the restric-
tions to variation in this antigenic region were largely lost after
serial passages of FMDV C-S8c1 in BHK-21 cells.
To determine whether the FMDV C-S8c1p100 population
incorporated additional amino acid substitutions during the
100 passages in BHK-21 cells, the sequence of the entire capsid
coding region was determined for one FMDV C-S8c1p100-
derived mutant (Asp-143-Gly, see Table 1), and for a plaque-
purified wild-type clone (c10) isolated from population FMDV
C-S8c1p100 in the absence of mAb SD6. Apart from the
Table 1. SD6 epitope MARMs isolated from FMDV C-S8c1 and
FMDV C-S8c1p100
Mutation*
Amino acid
substitution†
No. of mutants
C-S8c1 C-S8c1p100
G(412) 3 C Ala-138 3 Pro 1 0
C(413) 3 A Ala-138 3 Asp 3 1
A(415) 3 C Ser-139 3 Arg 2 0
A(415) 3 G Ser-139 3 Gly 2 0
G(416) 3 A Ser-139 3 Asn 8 2
G(416) 3 T Ser-139 3 Ile 17 8
T(417) 3 A Ser-139 3 Arg 2 0
T(417) 3 G Ser-139 3 Arg 16 0
G(425) 3 A Gly-142 3 Glu 0 4
A(428) 3 G Asp-143 3 Gly 0 1
T(430) 3 G Leu-144 3 Val 0 5
T(431) 3 C Leu-144 3 Ser 0 8
C(434) 3 T Ala-145 3 Val 0 2
A(437) 3 G His-146 3 Arg 31 0
A(437) 3 G His-146 3 Arg
C(446) 3 T Thr-149 3 Met 1 0
*The first letter corresponds to the wild-type nucleotide; the number
gives nucleotide position in the VP1-coding region; the last letter
corresponds to the mutant nucleotide.
†The first amino acid is the one found in the wild-type virus; the
number gives the amino acid position in VP1; the second amino acid
is the one found in the different MARMs. The vertical line indicates
the isolation of a double mutant.
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mutation responsible for resistance to SD6 in the mutant
clone, both clones differed from C-S8c1 in six capsid amino
acids (Table 2). Three of them were located in capsid protein
VP1 and three in VP3. With the exception of Ala-25-Val in
VP3, all substitutions were located at the virion surface and
they clustered around the position found for the G–H loop of
VP1 in C-S8c1 (Fig. 2), suggesting they could have some
influence on the conformation of the G–H loop (see Discus-
sion).
Selection and Frequencies of FMDVs Resistant to Neutral-
ization by mAb SD6. To determine the frequencies of
MARMs, a MARM phenotypic assay with mAb SD6 was
carried out as described. The MARM frequencies obtained
were (8.5 6 1) 3 1024 for FMDV C-S8c1 and (4.1 6 0.5) 3
1023 for FMDV C-S8c1p100 (Table 3). Similar frequencies
were obtained with a MARM genotypic assay (mAb SD6
added only to the agar overlay after cell adsorption of viruses)
(data not shown). The large MARM frequencies obtained with
FMDV C-S8c1p100 could reflect either a special trait of the
complex quasispecies generated after many passages in
BHK-21 cells or a feature of the viral capsid irrespective of the
complexity of the viral population. To distinguish between
these two possibilities, the MARM frequencies of two plaque-
purified clones derived from population C-S8c1p100 were
obtained (Table 3). Although such biological clones develop
also into a quasispecies distribution, their complexity should be
lower than that of the parental C-S8c1 p100 population. The
large MARM frequencies found for both clones (Table 3)
indicate that the high MARM frequencies depended on a
feature of the viral particles and not on population complexity.
The substitutions found in C-S8p100c10 (Table 2) suggest the
relevance of the additional capsid amino acid substitutions in
determining the increased MARM frequencies of the multiply
passaged FMDV C-S8c1p100 population.
Replication Kinetics of Selected SD6 MARMs. The finding
of MARMs with substitutions at the previously thought in-
variant RGD sequence (Fig. 1 and Table 1) begged the
question as to their replication capacity. RGD is an essential
cell-binding motif, and in contrast to the present findings,
previous studies showed that BHK cells transfected with
FMDV RNAs containing changes within this sequence pro-
duced noninfectious virus (10). To determine whether the
substitutions found in SD6 MARMs influenced viral produc-
tion, one-step growth analysis was carried out with several
MARMs. The replication kinetics analysis included mutants
with substitutions at the RGD sequence, as well as the MARM
repertoire from FMDV C-S8c1p100 (Fig. 1). No differences
were found among the mutants and the parental virus
FIG. 1. Alignment of the amino acid sequences of the central
region of the VP1 G–H loop of FMDV C-S8c1 and SD6 epitope
MARMs. The single-letter amino acid code is used. Numbering is
according to that for FMDV C-S8c1. Antigenic site A of type C viruses
involves residues 136–150. The continuous epitope recognized by mAb
SD6 is underlined. The RGD triplet is boxed. Solid triangles corre-
spond to amino acid residues that cannot be replaced by most other
amino acids with regard to binding to SD6; open triangles indicate
residues that can be replaced by some other residues without having
a drastic effect on SD6 recognition; residues 137 and 140 were
generally replaceable without affecting SD6 recognition (ref. 33 and
M.G.M. and E.D., unpublished work). These results are also consistent
with structural data regarding the mAb SD6–G–H loop peptide
interaction (23).
FIG. 2. Location of the amino acid substitutions found in FMDV C-S8c1p100c10 on the virus capsid. Stereoview of a ribbon protein diagram
of a crystallographic protomer of C-S8c1 in which the relevant substitutions have been modeled (see Materials and Methods). The capsid proteins
VP1, VP2, and VP3 are indicated as dark, medium, and light grey, respectively. VP4 is entirely internal and has not been included for clarity. VP1
from a neighboring protomer is shown on the left side (dark grey). The substituted residues are depicted in CPK representation. The position of
the G–H loop of VP1 in C-S8c1 complexed with mAb SD6 is indicated in light grey (37).
Table 2. Capsid amino acids found in FMDV C-S8c1p100c10 and
FMDV C-S8c1p100 MARM (Asp-143-Gly), which differ from
FMDV C-S8c1
Secondary
structure* Position†
Amino acid
substitution
VP1 bB strand 41 Lys3 Glu
VP1 B–C loop 46 Asp3 Glu
VP1 C terminus 197 His3 Arg
VP3 N terminus 25 Ala3 Val
VP3 G–H loop 173 Glu3 Lys
VP3 C terminus 218 Gln3 Lys
*Secondary structure assignments are as described in ref. 36.
†Only positions different from those in FMDV C-S8c1 are shown.
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C-S8c1p100, demonstrating that substitutions at the RGD
sequence or in surrounding residues did not affect the virus
replication capacity (Fig. 3). Furthermore, the RNA from
viruses recovered at 20 hr after infection (Fig. 3) were PCR
amplified and their nucleotide sequence showed no signs of
reversion at the relevant mutant positions, nor the presence of
additional substitutions (data not shown). Likewise, no de-
tectable reduction in the number of plaques was observed in
the progeny mutants in a neutralization assay with mAb SD6
indicating maintenance of the MARM phenotype. As ex-
pected, the parental virus C-S8c1, with a limited passage
history in BHK-21 cells (27), shows a delay in its replication
kinetics relative to C-S8c1p100 and to all the mutants tested
(Fig. 3).
DISCUSSION
The high mutation rates operating during RNA virus replica-
tion create complex quasispecies. Because such a complexity is
generated in a highly probabilistic fashion due to the stochastic
process of mutagenesis, the behavior of RNA virus popula-
tions is often unpredictable (6). Here we show that large
FMDV populations serially propagated in cell culture, with
constant environmental conditions, generate a different anti-
genic repertoire. Interestingly, this new antigenic repertoire
includes variants with substitutions at the RGD motif (Gly-
142-Glu and Asp-143-Gly) (Fig. 1), previously proposed to be
essential for the viability of FMDV. The 86 mutants isolated
from FMDV C-S8c1 (Table 1), together with many field
viruses and laboratory variants sequenced (29, 36, 38–42)
should be sufficient to consider FMDV of serotype C highly
intolerant to amino acid substitutions at the RGD motif and
several contiguous residues. Work with peptides indicates that,
in addition to the RGD triplet, neighboring residues 144, 145,
and 147 are also involved in receptor recognition of C-S8c1
(13), thus explaining their high degree of conservation. The
relevance of the RGD motif in cell recognition of FMDV has
been confirmed by studies of infectivity with cells transfected
with the relevant integrin genes, and by site-directed mutagen-
esis of the critical loop residues (10, 11, 14, 43). The mAb SD6
MARM repertoire found in the FMDV C-S8c1p100 popula-
tion, with substitutions in VP1 residues 141–145 (Table 1 and
Fig. 1), clearly demonstrates the loss of restrictions to variation
in this highly conserved region. Structural and immunochemi-
cal work have shown that all the residues found substituted in
the SD6 MARMs (Fig. 1) interact with mAb SD6 (refs. 23 and
33 and references therein).
Using the atomic coordinates of FMDV C-S8c1 obtained by
x-ray crystallography (18), the substitutions found in the capsid
of FMDV C-S8c1p100 mutant Asp-143-Gly and of a plaque-
purified wild-type clone (c10) isolated from C-S8c1p100 (Ta-
ble 2) have been modeled on the capsid structure (Fig. 2). The
G–H loop of VP1 is disordered in the crystal structures
determined for native FMDVs. However, the structure of
C-S8c1 complexed with the Fab fragment of mAb SD6 has
been recently determined by cryoelectron microscopy (37);
this allowed the positioning of the G–H loop on the capsid
(Fig. 2). It may be significant that five of the six amino acid
replacements found in the C-S8c1p100 clones relative to
C-S8c1 cluster around the position found for the G–H loop.
Substitutions at the B–C loop of VP1 of FMDV type O have
been proposed to affect antibody recognition of the G–H loop
by forcing this f lexible loop to a different position (44). In
addition, the conformation adopted by the RGD triplet within
the G–H loop is probably critical for receptor binding (13).
Furthermore, recent evidence suggests that FMDV of serotype
O uses also heparan sulfate to interact with the cell (45). Thus,
it is tempting to propose that some of the mutations in
C-S8c1p100 may alter cell recognition of FMDV. Dispensabil-
ity of the RGD could reflect either relaxation of the structural
features needed to recognize a cellular integrin or the acqui-
sition by FMDV of the ability to recognize an entirely new
receptor molecule. It is noteworthy that the virus harbors,
within the mutant spectrum of the evolving quasispecies, the
evolutionary potential to render dispensable a receptor–
recognition motif and to ensure an alternative pathway for
normal viral replication. This implies a close relationship
between antigenic variation and changes in cell tropism at-
tained in the absence of immune selection and in a constant
cell culture environment.
Wimmer and coworkers (24, 46**) have suggested that the
involvement of some poliovirus capsid residues in antigenic
determinants and in receptor binding could lead to the emer-
gence of new enterovirus species with altered tissue tropism.
Experiments are in progress to try to elucidate whether
C-S8c1p100 and the mAb SD6 MARMs derived from it,
especially those with substitutions in the RGD motif, have an
altered cell tropism. The results reported here emphasize the
great adaptive potential of RNA viruses. Indeed their genetic
f lexibility extends to rendering dispensable highly conserved
functional domains due to variations occurring in a constant
biological environment. This has clear implications for the
emergence of new viruses in nature.
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FIG. 3. Replication of SD6 epitope MARMs. BHK-21 cells were
infected with SD6 MARMs isolated from FMDV C-S8c1p100 and
wild-type viruses C-S8c1 and C-S8c1p100 at a multiplicity of infection
of 10 pfu per cell. Virus titer at different times after infection was
determined by plaque assay in BHK-21 cells. Each time point is the
average of duplicate samples.
Table 3. Frequencies of SD6 epitope MARMs in populations
FMDV C-S8c1 and FMDV C-S8c1p100, and some
clonal derivatives
Viruses*
No. of
assays Frequency of MARM
C-S8c1 3 (8.5 6 1.0) 3 1024
C-S8c1p100 3 (4.1 6 0.5) 3 1023
C-S8c1p100c1 3 (8.7 6 0.3) 3 1023
C-S8c1p100c10 3 (8.5 6 2.0) 3 1023
*C-S8c1p100 is the initial FMDV C-S8c1 propagated 100 times in cell
culture. C-S8c1p100c1 and C-S8c1p100c10 are two independent
clones isolated from the FMDV C-S8c1p100 population.
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